Head Lemming, you're not the CEO are you? Saying that there was a competitor but they were not really a competitor and they had X amount of injection site reactions and so on. What you should know is that the FDA didn't let the patients CHANGE their injection site from the whole time the trial was on-going. Also, unlike the gut-buster drug the doseage was constant. We'll see HL who's right. t